Dr Maxwell Sushil Lall, DPM in Little Rock, AR - Medicare Student in an Organized Health Care Education/Training Program Provider

Dr Maxwell Sushil Lall, DPM is a medicare enrolled "Student In An Organized Health Care Education/training Program" provider in Little Rock, Arkansas. His current practice location is 4300 W 7th St, Little Rock, Arkansas. You can reach out to his office (for appointments etc.) via phone at (501) 257-1000.

Dr Maxwell Sushil Lall is licensed to practice in * (Not Available) (license number ) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1770102691.

Contact Information

	Dr Maxwell Sushil Lall, DPM
	4300 W 7th St, Little Rock, AR 72205-5446
	(501) 257-1000
	Not Available

Healthcare Provider's Profile

Full Name	Dr Maxwell Sushil Lall
Gender	Male
Speciality	Student In An Organized Health Care Education/training Program
Location	4300 W 7th St, Little Rock, Arkansas
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1770102691
Provider Enumeration Date: 04/10/2020
Last Update Date: 07/28/2023

Medicare PECOS Information:

PECOS PAC ID: 9537590500
Enrollment ID: I20200506001486

Medical Identifiers

Medical identifiers for Dr Maxwell Sushil Lall such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1770102691	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
213ES0103X	Podiatrist - Foot & Ankle Surgery	303 (Arkansas)	Secondary
390200000X	Student In An Organized Health Care Education/training Program	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Maxwell Sushil Lall is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Maxwell Sushil Lall, DPM 4219 Redding Cir, Grand Blanc, MI 48439-7311 Ph: (810) 265-3644	Dr Maxwell Sushil Lall, DPM 4300 W 7th St, Little Rock, AR 72205-5446 Ph: (501) 257-1000

News Archive

Tobacco smoking and vaping nicotine may exacerbate COVID-19 inflammation

Researchers in San Diego have conducted a study showing that both smoking and the use of e-cigarettes containing nicotine and flavorings may critically exacerbate inflammation in cases of coronavirus disease 2019 (COVID-19) and significantly worsen clinical outcomes.

Intellipharmaceutics announces dismissal of patent litigation settlement on Focalin XR drug

Intellipharmaceutics International Inc. and its wholly owned subsidiary Intellipharmaceutics Corp. today announced that it and its licensee and development partner Par Pharmaceutical, Inc. ("Par") have received confirmation that the previously announced stays of the patent litigation concerning a generic version of Novartis' Attention Deficit Hyperactivity Disorder drug, Focalin XR®, (dexmethylphenidate hydrochloride), have expired without regulatory intervention, and that the parties have stipulated to a dismissal of the litigation.

Apitope-led consortium awarded FP7 Health Innovation funding to develop Graves' disease vaccine

Apitope, the drug discovery and development company focused on treating the underlying cause of autoimmune diseases, today announces that the consortium, led by Apitope, which includes GSK Vaccines, Quintiles and KWS Biotest Limited, has been awarded prestigious Framework Programme 7 Health Innovation funding by the European Commission to develop its Graves' disease therapeutic vaccine, including a Phase I first-in-man study in Graves' disease patients.

Higher coronary artery calcium levels in middle-age linked to increased risk for future heart problems

Higher coronary artery calcium levels in middle-age were associated with structural heart abnormalities linked to future heart failure, particularly among blacks, according to new research in Circulation: Cardiovascular Imaging, an American Heart Association journal.

Dr Maxwell Sushil Lall, DPM - Medicare in Little Rock, AR